Why the study?
Is implantable cardioverter-defibrillator (ICD) therapy cost-effective in patients at high risk of sudden cardiac death?
Is implantable cardioverter-defibrillator (ICD) therapy cost-effective in patients at high risk of sudden cardiac death?
ICD therapy is a cost-effective investment for prolonging survival in appropriately selected patients at high risk of sudden cardiac death, especially when evaluated over long time horizons.
No takes yet. Share an insight, caveat, or question.
May inform ICD decisions in high-risk patients; leaves open need for updated economic models in contemporary practice.
Leyva et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: